Management of collagen vascular diseases in childhood

Dermatologic Clinics

Volumn 16, Issue 3, 1998, Pages 579-592

  DeSilva, T N ^a   Kress, D W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; ARTIFICIAL TEAR; AUTOANTIBODY; AZATHIOPRINE; CHLOROQUINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFLAZACORT; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; ISOTRETINOIN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

CHILDHOOD DISEASE; COLLAGEN DISEASE; DERMATOMYOSITIS; DISCOID LUPUS ERYTHEMATOSUS; DRUG COST; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HYPERSENSITIVITY REACTION; INTRAVENOUS DRUG ADMINISTRATION; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; MALE INFERTILITY; ORAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; REVIEW; SCLERODERMA; SJOEGREN SYNDROME; SKIN BLOOD VESSEL DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031819258     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70254-0     Document Type: Article

References (129)

1. C. Abud-Mendoza A.K. Sturbaum R. Vazquez-Compean Methotrexate therapy in childhood systemic lupus erythematosus J Rheumatol 20 1993 731
2. S. Ahmad Scleroderma and impotence: Response to nitroglycerin applied to the fingers and penis (letter) South Med J 83 1990 1495
3. K. Akashi K. Nagasawa T. Mayumi Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins J Rheumatol 17 1990 375
4. D. Alarcon-Segovia F. Ramos-Niembro G. Ibanez de Kasep Long-term evaluation of colchicine in the treatment of scleroderma J Rheumatol 6 1979 705
5. J.M. Anaya N. Ogawa N. Talal Sjogren's syndrome in childhood J Rheumatol 22 6 1995 1152
6. B.M. Ansell F. Falcini P. Woo Scleroderma in childhood Clinical Dermatology 12 1994 299
7. B.Q. Banker M. Victor Dermatomyositis (systemic angiopathy) of childhood Medicine 45 4 1966 261
8. K.S. Barron M.R. Sher E.D. Silverman Intravenous immunoglobulin therapy: Magic or black magic J Rheumatol 19 33 1992 94
9. F.Z. Bierman L. Baxi I. Jaffe Fetal hydrops and congenital complete heart block: Response to maternal steroid therapy J Pediatr 112 1988 646
10. C.M. Black Prognosis and management of scleroderma and scleroderma-like disorders in children Clin Exp Rheumatol 12 10 1994 S75
11. M. Blaszczyk C. Krysicka-Janniger S. Jablonska Childhood scleroderma and its peculiarities Cutis 58 1996 141
12. A. Bohan J.B. Peter Polymyositis and dermatomyositis N Engl J Med 292 7 1975 344
13. A. Bohan J.B. Peter Polymyositis and dermatomyositis N Engl J Med 292 8 1975 403
14. W.W. Bottomley M. Goodfield Methotrexate for the treatment of severe mucocutaneous lupus erythematosus Br J Dermatol 133 1995 311
15. S.L. Bowyer C.E. Blane D.B. Sullivan Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcification J Pediatr 103 1983 882
16. E.J. Brewer E.H. Giannini N. Kuzmina d -penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis: Results of the USA–USSR double-blind, placebo controlled trial N Engl J Med 314 1986 1269
17. M.D. Brown C. Ellis J.J. Voorhees Cyclosporine A: A review of its dermatologic applications Semin Dermatol 6 1 1987 2
18. J.P. Buyon S.H. Swersky H.E. Fox Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus: Experience in a mother with a predominance of SS-B (La) antibodies Arthritis Rheum 30 1987 44
19. V. Bykerk J. Sampalis J.M. Esdaile A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus N Engl J Med 324 3 1991 150
20. J.P. Callen Dermatomyositis and malignancy Clinics Rheumatologic Disease 8 1982 369
21. H.M. Cann H.L. Verhulst Fatal acute poisoning in children Pediatrics 27 1961 95
22. J.T. Cassidy D.B. Sullivan L. Dabich Scleroderma in children Arthritis Rheum 20 1977 351
23. J.W. Casson M.L. Barringer R.E. Jones Fatal chloroquine ingestion Pediatrics 40 1967 449
24. L.J. Catoggio R.M. Bernstein C.M. Black Serological markers in progressive systemic sclerosis: Clinical correlations Ann Rheum Dis 42 1983 23
25. P.J. Clements P.A. Lachenbruch M. Sterz Cyclosporine in systemic sclerosis: Results of a forty-eight week open safety study in ten patients Arthritis Rheum 36 1993 75
26. R.K. Curley A.W. MacFarlane S. Evans The treatment of linear morphoea with d -penicillamine Clin Exp Dermatol 12 1987 56
27. P.C. Dau M.B. Kahaleh R.W. Sagebiel Plasmapheresis and immunosuppressive drug therapy in scleroderma Arthritis Rheum 24 9 1981 1128
28. R.L. Dawkins P.J. Zilko J. Carrano Immunobiology of d -penicillamine J Rheumatol 8 1981 56
29. B.A. Denardo L.B. Tucker L.C. Miller Demography of a regional pediatric rheumatology patient population J Rheumatol 21 1994 1553
30. A. De Wilde I.S. Szer A.S. Klainer Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: A case report Arch Dermatol 128 1992 1656
31. V.J.M. DiMaio L.D. Henry Chloroquine poisoning South Med J 67 1974 1031
32. A.A. Drosos E.K. Tsiakou N. Tsifetaki Subgroups of primary Sjogren's syndrome. Sjogren's syndrome in male and paediatric Greek patients Ann Rheum Dis 56 1997 333
33. E.L. Dubois Antimalarials in the management of discoid and systemic lupus erythematosus Semin Arthritis Rheum 8 1 1978 33
34. C.M. Duffy R.M. Laxer P. Lee Raynaud syndrome in childhood J Pediatr 114 1989 73
35. H.M. Emery Treatment of juvenile rheumatoid arthritis Curr Opin Rheumatol 5 1993 629
36. E. Esscher J.S. Scott Congenital heart block and maternal systemic lupus erythematosus BMJ 1 1979 1235
37. V. Falanga Localized scleroderma Med Clin North Am 73 1989 1143
38. V. Falanga T.A. Medsger d -penicillamine in the treatment of localized scleroderma Arch Dermatol 126 1990 609
39. D.T. Felson J. Anderson Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis N Engl J Med 311 24 1984 1528
40. J. Ferraris P. Day P. Gutman Effect of therapy with a new glucocorticoid, Deflazacort, on linear growth and growth hormone secretion after renal transplantation J Pediatr 121 1992 809
41. M.B. Ferraz J. Goldenberg M.O. Hilario Evaluation of the 1982 ARA lupus criteria data set in pediatric patients Clin Exp Rheumatol 12 1994 83
42. C.W. Fink Overview of corticosteroid therapy in the different rheumatic diseases of childhood Clin Exp Rheumatol 9 suppl 1991 9
43. A.J. Fish E.B. Blau N.G. Westberg Systemic lupus erythematosus within the first two decades of life Am J Med 62 1977 99
44. G. Gaedicke W.M. Teller E. Kohne IgG therapy in systemic lupus erythematosus—case reports Blut 48 1984 387
45. P.M. George A.F. Hood E.B. Rest Histopathology and immunofluorescence of discoid lupus erythematosus in children Pediatr Dermatol 13 4 1996 269
46. E.H. Giannini J.T. Cassidy Methotrexate in juvenile rheumatoid arthritis Do the benefits outweigh the risks? Drug Safety 9 5 1993 325
47. E.H. Giannini G. Dunkel-Cawkwell Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future Pediatr Clin North Am 42 1995 1099
48. E.H. Giannini D.J. Lovell E.D. Silverman Intravenous immune globulin in polyarticular JRA. Results of a phase I/II trial (abstr) Arthritis Rheum 37 suppl 1994 S276
49. R.S. Glidden E.C. Mantzouranis Y. Borel Systemic lupus erythematosus in childhood: Clinical manifestations and improved survival in fifty-five patients Clin Immunol Immunopathol 29 1983 196
50. D.P. Goldsmith Neonatal rheumatic disorders: View of the pediatrician Rheum Dis Clin North Am 15 1989 287
51. D.K. Gupta L.K. Sharma Acute chloroquine toxicity in infants Indian J Pediatr 17 1980 309
52. V. Hanson Dermatomyositis, scleroderma and polyarteritis nodosa Clin Rheum Dis 2 2 1976 445
53. J. Heckmatt N. Hasson C. Saunders Cyclosporin in juvenile dermatomyositis Lancet 1989
54. R. Hein J. Behr M. Hundgen Treatment of systemic sclerosis with gamma-interferon Br J Dermatol 126 1992 496
55. G. Herreman N. Galezewski Maternal connective tissue disease and congenital heart block (letter) N Engl J Med 312 1985 1329
56. C.A. Heyneman C.A. Gudger J.V. Beckwith Intravenous immune globulin for inducing remissions in systemic lupus erythematosus Ann Pharmacother 31 1997 242
57. M.M. Hulshof S. Pavel F.C. Breedveld Oral calcitriol as a new therapeutic modality for generalized morphea Arch Dermatol 130 1994 1290
58. S. Hurwitz The collagen vascular disorders S. Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence 2nd ed. 1993 WB Saunders Philadelphia
59. L.F. Imundo J.C. Jacobs Treatment of juvenile arthritis (JA) with sulfasalazine (abstr) Arthritis Rheum 36 suppl 1993 S122
60. D. Isaacson M. Elgart M.L. Turner Anti-malarials in dermatology Intl J Dermatol 21 7 1982 379
61. J.C. Jacobs Methotrexate and azathioprine treatment of childhood dermatomyositis Pediatrics 59 2 1977 212
62. E.M. Jones J.P. Callen Collagen vascular diseases of childhood Pediatr Clin North Am 38 1991 1019
63. R.A. Kaplan D.M. Ward Plasmapheresis plus steroid and cytotoxic therapy in scleroderma Arthritis Rheum 29 suppl 1986 24
64. M. Kerscher T. Dirschka M. Volkenandt Treatment of localised scleroderma by UVA-1 phototherapy Lancet 346 1995 1166
65. M. Kerscher M. Volkenandt M. Meurer Treatment of localised scleroderma with PUVA bath photochemotherapy Lancet 343 1994 1233
66. M.A. Khamashta G.R.V. Hughes Pregnancy in systemic lupus erythematosus Curr Opin Rheumatol 8 1996 424
67. I. Kobayashi H. Furuta A. Tame Complications of childhood Sjogren syndrome Eur J Pediatr 155 1996 890
68. F.C. Koranda Antimalarials J Am Acad Dermatol 4 1981 650
69. K. Koster-King H.K. Kornreich B.H. Bernstein The clinical spectrum of systemic lupus erythematosus in childhood Arthritis Rheum 20 1977 287
70. R.M. Laxer E.A. Roberts K.R. Gross Liver disease in neonatal lupus erythematosus J Pediatr 116 1990 238
71. L.A. Lee W.L. Weston Lupus erythematosus in childhood Dermatol Clin 4 1986 151
72. T.J.A. Lehman Systemic and localized scleroderma in children Curr Opin Rheum 8 1996 576
73. T.J.A. Lehman D.K. McCurdy B.H. Bernstein Systemic lupus erythematosus in the first decade of life Pediatrics 83 2 1989 235
74. W.F. Lever G. Schaumburg-Lever Connective tissue diseases W.F. Lever G. Schaumburg-Lever Histopathology of the Skin 7th ed. 1990 JB Lippincott Philadelphia 507
75. H.B. Lovell C.B. Lindsley Late recurrence of childhood dermatomyositis J Rheumatol 13 1986 821
76. H.A. Markowitz J.M. McGinley Chloroquine poisoning in a child JAMA 189 1964 950
77. D.P. McCauliffe Neonatal lupus erythematosus: A transplacentally acquired disorder Semin Dermatol 14 1 1995 47
78. A.B. McCune W.L. Weston L.A. Lee Maternal and fetal outcome in neonatal lupus erythematosus Ann Intern Med 106 1987 518
79. T.A. Medsger Epidemiology of systemic sclerosis Clin Dermatol 12 1994 207
80. L.C. Miller B.A. Sillon L.B. Tucker Methotrexate treatment of recalcitrant childhood dermatomyositis Arthritis Rheum 35 10 1992 1143
81. M.L. Miller Juvenile rheumatoid arthritis Curr Probl Pediatr 24 1994 290
82. E.J. Moynahan Morphoea (localized cutaneous scleroderma) treated with low-dosage penicillamine (4 cases, including en coup de sabre) Proceedings of the Royal Society of Medicine 66 1973 1083
83. A.M. Nelson Localized scleroderma including morphea, linear scleroderma, and eosinophilic fasciitis Curr Probl Pediatr 26 1996 318
84. M.E. Nimni Penicillamine and collagen metabolism Scand J Rheumatol 8 1979 71
85. P.A. Ostuni A. Ianniello S.G. Mazzola Juvenile onset of primary Sjogren's syndrome: report of 10 cases Clin Exp Rheumatol 14 1996 689
86. L.M. Pachman Juvenile dermatomyositis: a clinical overview Pediatr Rev 12 4 1990 117
87. L.M. Pachman A.M. Callen J. Hayford Juvenile dermatomyositis: Decreased calcinosis with intermittent high-dose intravenous methylprednisolone therapy Arthritis Rheum 37 1994 S429
88. L.M. Pachman N. Cooke Juvenile dermatomyositis: A clinical and immunologic study J Pediatr 96 2 1980 226
89. A.S. Paller The use of corticosteroid therapy for juvenile dermatomyositis Pediatr Dermatol 13 4 1996 347
90. D. Pariente J.M. Anaya B. Combe Non-Hodgkin's lymphoma associated with primary Sjogren's syndrome Eur J Med 1 1992 337
91. R.M. Pertusi B.R. Rubin D. Blackwell Juvenile rheumatoid arthritis JAOA 96 5 1996 298
92. M. Petri R. Watson M.C. Hochberg Anti-Ro antibodies and neonatal lupus Rheum Dis Clin North Am 15 1989 335
93. T.T. Provost R. Watson K.K. Gaithers The neonatal lupus erythematosus syndrome J Rheumatol 14 1987 199
94. T.T. Provost R.M. Watson W.R. Gammon The neonatal lupus erythematosus syndrome associated with U1 RNP (nRNP) antibodies N Engl J Med 316 1987 1135
95. S.D. Prystowsky J.H. Herndon J.N. Gilliam Chronic cutaneous lupus erythematosus (DLE): A clinical and laboratory investigation of 80 patients Medicine 55 1975 183
96. J.E. Rasmussen Antimalarials—are they safe to use in children? Pediatr Dermatol 1 1 1983 89
97. D.S. Richards A.J. Wagman M.L. Cabaniss Ascites not due to congestive heart failure in a fetus with lupus-induced heart block Obstet Gynecol 76 1990 957
98. L.G. Rider J.P. Buyon J. Rutledge Treatment of neonatal lupus: Case report and review of the literature J Rheumatol 20 7 1993 1208
99. H.M. Roberts L.A. Brunsting Dermatomyositis in childhood Postgrad Med J 16 1954 396
100. N.R. Rockerbie T.Y. Woo J.P. Callen Cutaneous changes of dermatomyositis precede muscle weakness J Am Acad Dermatol 20 4 1989 629
101. A.H. Rook B. Freundlich B.V. Jegasothy Treatment of systemic sclerosis with extracorporeal photochemotherapy Arch Dermatol 128 1992 337
102. J. Schaller Lupus in childhood Clin Rheum Dis 8 1 1982 219
103. J.G. Schaller Aggressive treatment in childhood rheumatic diseases Clin Exp Rheumatol 12 10 1994 S97
104. K. Scharffetter M. Wlaschek A. Hogg UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo Arch Dermatol Res 283 1991 506
105. D. Schorn M.J.O. Francis M. Loudon Skin collagen biosynthesis in patients with rheumatoid arthritis treated with d -penicillamine Scand J Rheumatol 8 1979 124
106. J.K. Shornick N. Formica A.L. Parke Isotretinoin for refractory lupus erythematosus J Am Acad Dermatol 24 1991 39
107. E. Silverman What's new in the treatment of pediatric SLE J Rheumatol 23 1996 1657
108. V.D. Steen T.A. Medsger G.P. Rodnan d -penicillamine therapy in progressive systemic sclerosis (scleroderma): A retrospective analysis Ann Intern Med 97 1982 652
109. W. Stevens R. Vancheeswaran C.M. Black Alpha interferon-2a (roferon-A) in the treatment of diffuse cutaneous systemic sclerosis: A pilot study Br J Rheumatol 31 1992 683
110. G.M. Tibbitts Juvenile rheumatoid arthritis. Old challenges, new insights Postgrad Med J 96 2 1994 75
111. H.A.W.M. Tiddens J.J. van der Net E.R. de Graeff-Meeder Juvenile-onset mixed connective tissue disease: Longitudinal follow-up J Pediatr 122 1993 191
112. C.E. Tseng J.P. Buyon Neonatal lupus syndromes Rheum Dis Clin North Am 23 1997 31
113. L.B. Tucker Juvenile rheumatoid arthritis Curr Opin Rheumatol 5 1993 619
114. J. Uitto P. Helin O. Rasmussen Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of d -penicillamine Ann Clin Res 2 1970 228
115. Y. Uziel M.L. Miller R.M. Laxer Scleroderma in children Pediatr Clin North Am 42 1995 1171
116. F.H. Van den Hoogen A.M. Boerbooms L.B. van de Putte Methotrexate treatment in scleroderma Am J Med 87 1989 116
117. M.A.J. Van Rossum I. Hiemstra A.M. Prieur Juvenile dermato/polymyositis: A retrospective analysis of 33 cases with special focus on initial CPK levels Clin Exp Rheumatol 12 1994 339
118. C. Vitali S. Bombardieri H.M. Moutsopoulos Preliminary criteria for the classification of Sjogren's syndrome Arthritis Rheum 36 1993 340
119. F. Wach H. Ullrich G. Schmitz Treatment of severe localized scleroderma by plasmapheresis— report of three cases Br J Dermatol 133 1995 605
120. C. Wallace J.G. Schaller H. Emery Prospective study of childhood systemic lupus erythematosus (SLE) Arthritis Rheum 21 1978 599
121. C.A. Wallace New uses of methotrexate Contemporary Pediatrics 11 1994 43
122. J. Waltuck J.P. Buyon Autoantibody-associated congenital heart block: outcome in mothers and children Ann Intern Med 120 1994 544
123. J. Waltuck J.P. Buyon Neonatal and maternal outcome in complete heart block (abstr) Arthritis Rheum 9 suppl 1992 S60
124. B.A.E. Walz-LeBlanc P. Dagenais M.B. Urowitz Methotrexate in systemic lupus erythematosus J Rheumatol 21 5 1994 836
125. W.J. Watson V.L. Katz Steroid therapy for hydrops associated with antibody-mediated congenital heart block Am J Obstet Gynecol 165 1991 553
126. P.H. White Pediatric systemic lupus erythematosus and neonatal lupus Rheum Dis Clin North Am 20 1994 119
127. R.K. Winkelmann Chronic discoid lupus erythematosus in children JAMA 205 1968 85
128. R.K. Winkelmann Dermatomyositis in childhood Clin Rheum Dis 8 1982 353
129. T.Y. Woo J.P. Callen J.J. Voorhees Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine J Am Acad Dermatol 10 1984 592